Anti- dsDNA antistoffer blev påvist første gang hos cirka 17% af infliximabbehandlede patienter sammenlignet med 0% af placebobehandlede patienter.
Anti- dsDNA antibodies were newly detected in approximately 17% of infliximab-treated patients compared with 0% of placebo-treated patients.